Neuroptics Inc.

7 articles with Neuroptics Inc.

• ADDING MULTIMEDIA – NeurOptics Launches New NPi®-300 Automated Pupillometer

  7/8/2021

  NeurOptics, the worldwide leader in the science of pupillometry, announced the U.S. launch of its NPi®-300, a next-generation automated pupillometer that enhances pupillary assessment to assist in detecting cerebral insult, guiding treatment and informing prognosis for clinicians and their patients.

• NeurOptics Launches New NPi®-300 Automated Pupillometer

  7/8/2021

  NeurOptics, the worldwide leader in the science of pupillometry, announced the U.S. launch of its NPi®-300, a next-generation automated pupillometer that enhances pupillary assessment to assist in detecting cerebral insult, guiding treatment and informing prognosis for clinicians and their patients.

• Case Study Series Published in Journal of Neuroscience Nursing Demonstrates NeurOptics’ Pupillometry is Key Tool for Neurological Assessment

  5/11/2021

  Study shows automated pupillometry provides reliable and objective pupil reactivity measurements that may impact treatment decisions for stroke patients

• NeurOptics Launches Virtual Pupillometry Education Platform

  2/23/2021

  Symposiums will demonstrate clinical utility and introduce practitioners to pupillometry and NPi as a valuable measurement in managing patients at risk of brain injury

• Neuroptics Inc. Appoints Neurocritical Care Industry Veteran William Worthen as President

  6/18/2013

• Study Shows Neuroptics Inc. Pupillometers Reliably Measure Pupillary Light Reflex, Helping to Predict Survival and Neurological Outcome After Cardiac Arrest

  10/2/2012

• Neuroptics Inc. Introduces First Hand-held Variable Light Condition Pupillometer to Optimize Outcomes for Refractive Surgery and Premium Intraocular Lens Candidates

  9/7/2011